About
BioMarCare uses a multi-biomarker panel approach to generate molecular blood tests andtissue-based diagnostic (IHC) tests with high specificity and sensitivity for use in the early diagnosis of cancer. The companys Colon-MarCarePlex is an accurate, patient-friendly colorectal cancer screening test that measures the expression of several genes thatserve as biomarkers to detect colorectal cancer. It offers fast, affordable results with no bowel preparation, no diet or medication restrictions, and no handling of stool. Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early-stage colorectal cancer. BioMarCares MCRC-Strat is a semi-quantitative IHC assay using a protein biomarker combination designed to predict patient responses to drugs targeting the epidermal growth factor receptor. The product is being developed in collaboration with a U.S. partner.
Funding history · 1 round · $1.9M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was BioMarCare founded?
- BioMarCare was founded in January 2002.
- What is the primary focus of BioMarCare?
- BioMarCare focuses on developing molecular blood tests and tissue-based diagnostic (IHC) tests using a multi-biomarker panel approach for the early diagnosis of cancer.
- What is BioMarCare's status as of August 2020?
- As of August 2020, BioMarCare is inactive and ceased to operate.
- What is Colon-MarCarePlex?
- Colon-MarCarePlex is BioMarCare's molecular assay (qRT-PCR) designed for colorectal cancer screening, measuring gene expression biomarkers to detect advanced adenoma polyps and early-stage colorectal cancer.
- What is MCRC-Strat and who is BioMarCare collaborating with for its development?
- MCRC-Strat is a semi-quantitative IHC assay from BioMarCare that uses a protein biomarker combination to predict patient responses to drugs targeting the epidermal growth factor receptor. It is being developed in collaboration with a U.S. partner.
- How much funding has BioMarCare raised in total?
- BioMarCare has raised a total of $1,900,000 in funding. For full financing history, please refer to startupim.
- When did BioMarCare receive its Seed funding and who was an investor?
- BioMarCare received $1,000,000 in Seed funding in March 2012, with Micromedic as an investor.
- Did BioMarCare receive any grants?
- Yes, BioMarCare received a grant of $900,000 from the IIA in August 2011.
- Where is BioMarCare headquartered?
- BioMarCare is headquartered in Jerusalem, Israel.